Drug completed trial ORION 10 Long

Description

⋅ Sep 25, 2019 2:18 PM

Successful Completion pf phase 3 trial marks another discovery for the company and ready to bring the cardiovascular drug to another level.

Todays price @ 50.55

Trend Analysis catalyst

Comments

greyf1r3

⋅ Sep 26, 2019 1:08 PM

Buyout is next.